Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
BMC Pharmacol
2002 Jan 01;2:4. doi: 10.1186/1471-2210-2-4.
Show Gene links
Show Anatomy links
4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.
Russo J
,
Barnes A
,
Berger K
,
Desgrosellier J
,
Henderson J
,
Kanters A
,
Merkov L
.
???displayArticle.abstract???
BACKGROUND: The signal transduction pathways mediated by retinoic acid play a critical role in the regulation of cell growth and differentiation during embryogenesis and hematopoiesis as well as in a variety of tumor cell lines in culture. Following the reports that two members of the superfamily of aldehyde dehydrogenase (ALDH) enzymes, ALDH1A1 and ALDH1A2, were capable of catalyzing the oxidation of all-trans retinal to all-trans retinoic acid with submicromolar Km values, we initiated an investigation of the ability of 4-(N,N-dipropylamino)benzaldehyde (DPAB) to inhibit the oxidation of retinal by purified mouse and human ALDH1A1.
RESULTS: Our results show that DPAB potently inhibits retinal oxidation, with IC50 values of 0.11 and 0.13 microM for purified mouse and human ALDH1A1, respectively. Since the HL-60 human myeloid leukemic cell line has been used extensively to study the retinoic acid induced differentiation of HL-60 cells to granulocytes, and ALDH1A1 activity had previously been reported in HL-60 cells, we investigated the ability of DPAB to block differentiation of HL-60 promyelocytic leukemia cells exposed to retinal in culture. In HL-60 cells coincubated with 1 microM retinal and 50 microM DPAB for 144 hours, cell differentiation was inhibited only 30%. Furthermore, the NAD-dependent oxidation of propanal or retinal was less than 0.05 nmoles NADH formed/min-10(7) cells in spectrophotometric assays using HL-60 cell extracts.
CONCLUSION: Although ALDH1A1 may be the major catalytic activity for retinal oxidation in some retinoid-dependent mouse and Xenopus embryonic tissues and in adult human and mouse hematopoietic stem cells, another catalytic activity appears to synthesize the retinoic acid ligand necessary to stimulate the differentiation of HL-60 cells to end stage granulocytes.
Figure 1. Chemical structures for ALDH1A1 substrate and inhibitor. (A) substrate: all-trans retinal. (B) inhibitor: 4-(N,N-dipropylamino)benzaldehyde (DPAB).
Figure 2. Differentiation response of HL-60 cells to retinoids and ALDH inhibitors. Retinoid concentrations were 1 μM for all-trans retinal (Ral) and all-trans retinoic acid (RA). Inhibitor concentrations were 50 μM for 4-(N,N-dipropylamino)benzaldehyde (DPAB) and 4-(N,N-diethylamino)benzaldehyde (DEAB). Control (black squares). Ral (red diamonds). RA (green circles). Ral + DPAB (dark blue triangles). RA + DPAB (hatched light blue squares). Ral + DEAB (hatched dark red diamonds).
Figure 3. A schematic depicting the potential roles of different oxidative enzymes in retinoic acid biosynthesis and the differentiation vs. self-renewal response to the retinoic acid ligand at different stages of hematopoiesis. Hematopoietic stem cell (HSC). All-trans retinal (Ral). All-trans retinoic acid (RA).
Ang,
Stimulation of premature retinoic acid synthesis in Xenopus embryos following premature expression of aldehyde dehydrogenase ALDH1.
1999, Pubmed,
Xenbase
Ang,
Stimulation of premature retinoic acid synthesis in Xenopus embryos following premature expression of aldehyde dehydrogenase ALDH1.
1999,
Pubmed
,
Xenbase
Ang,
Retinoic acid biosynthetic enzyme ALDH1 localizes in a subset of retinoid-dependent tissues during xenopus development.
1999,
Pubmed
,
Xenbase
Barrera,
Enzymes metabolizing aldehydes in HL-60 human leukemic cells.
1999,
Pubmed
Bhat,
Properties of retinal-oxidizing enzyme activity in rat kidney.
1988,
Pubmed
Breitman,
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
1980,
Pubmed
Bunting,
De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality.
1996,
Pubmed
Chen,
Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes.
2000,
Pubmed
Colvin,
Enzymatic mechanisms of resistance to alkylating agents in tumor cells and normal tissues.
1988,
Pubmed
Dockham,
Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde.
1992,
Pubmed
Duester,
Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis.
1996,
Pubmed
Duester,
Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid.
2000,
Pubmed
Estey,
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.
1999,
Pubmed
Haselbeck,
Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways.
1999,
Pubmed
,
Xenbase
Hodges,
Demonstration of mRNA for five species of cytochrome P450 in human bone marrow, bone marrow-derived macrophages and human haemopoietic cell lines.
2000,
Pubmed
Jones,
Assessment of aldehyde dehydrogenase in viable cells.
1995,
Pubmed
Kastan,
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
1990,
Pubmed
Keung,
Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase.
1993,
Pubmed
Keung,
Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria.
1998,
Pubmed
Lamb,
The structure of retinal dehydrogenase type II at 2.7 A resolution: implications for retinal specificity.
1999,
Pubmed
Lee,
Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid.
1991,
Pubmed
Moore,
Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases.
1998,
Pubmed
Moreb,
Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.
1996,
Pubmed
Nervi,
Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.
1989,
Pubmed
Niederreither,
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development.
1999,
Pubmed
Purton,
All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors.
1999,
Pubmed
Purton,
All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells.
2000,
Pubmed
Raner,
Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
1996,
Pubmed
Russo,
Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde.
1988,
Pubmed
Russo,
Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of mouse and human class I aldehyde dehydrogenase.
1995,
Pubmed
Sophos,
Aldehyde dehydrogenase gene superfamily: the 2000 update.
2001,
Pubmed
Sreerama,
Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents.
1997,
Pubmed
Storms,
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.
1999,
Pubmed
Vasiliou,
Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping.
1999,
Pubmed
Wang,
Cloning of a cDNA encoding an aldehyde dehydrogenase and its expression in Escherichia coli. Recognition of retinal as substrate.
1996,
Pubmed
Zhao,
Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase.
1996,
Pubmed
